Limited Use Note(s)

Government of Ontario Logo
LORAZEPAM4mg/mL Inj Sol (with preservative)
Reason For Use CodeClinical Criteria
481For the management of patients receiving palliative care*.
LU Authorization Period: 1 year
NOTE: *The patient must have a progressive life-limiting illness and require this medication for palliative purposes.